2022-12-15 Redwood Pharma enters partnership with Nextec medical in preparation for European market clearance of RP501 Regulatory
2022-03-28 Redwood Pharma receives approval from the Austrian drug authority to start RP501 clinical trial Regulatory
2021-02-11 Redwood Pharma will receive approximately SEK 34.2 million through a heavily oversubscribed rights issue Regulatory
2021-01-18 Redwood Pharma announces intention to move to Nasdaq First North Growth Market stock exchange Regulatory
2020-09-08 Redwood Pharma launches new development program for mild dry eye based on its proprietary IntelliGel platform Regulatory
